Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia

被引:120
|
作者
Moorman, AV
Richards, SM
Martineau, M
Cheung, KL
Robinson, HM
Jalali, GR
Broadfield, ZJ
Harris, RL
Taylor, KE
Gibson, BES
Hann, IM
Hill, FGH
Kinsey, SE
Eden, TOB
Mitchell, CD
Harrison, CJ
机构
[1] Univ Southampton, Southampton Gen Hosp, Canc Sci Div, Leukaemia Res Fund Cytogenet Grp, Southampton SO16 6YD, Hants, England
[2] Univ Oxford, Clin Trial Serv Unit, Oxford, England
[3] Yorkhill Natl Hlth Serv Trust, Glasgow, Lanark, Scotland
[4] Great Ormond St Hosp Sick Children, London WC1N 3JH, England
[5] Birmingham Childrens Hosp NHS Trust, Birmingham, W Midlands, England
[6] St James Hosp, Leeds LS9 7TF, W Yorkshire, England
[7] Cent Manchester & Manchester Childrens Univ Hosp, Manchester, Lancs, England
[8] John Radcliffe Hosp, Oxford OX3 9DU, England
关键词
D O I
10.1182/blood-2003-04-1128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High hyperdiploidy (HeH) (51 to 65 chromosomes) is found in one third of children with acute lymphoblastic leukemia and is associated with a good prognosis. Cytogenetic features may further refine this prognosis and identify patients with a poor outcome. We examined the effect of sex, age, individual trisomies, modal number, and structural abnormalities on survival among 700 children with HeH. Univariate analysis showed that age. sex, +4, +10, +18, and a high modal number were associated with survival. Multivariate analysis however, revealed that only age, sex, +4, and +18 were independent indicators. Hazard scores for predicting relapse and mortality were constructed. Three risk groups with 5-year event-free survival (EFS) rates of 86%,75%, and 50% (P < .0001) were identified. The high-risk group comprised boys older than 9 years, boys aged 1 through 9 years without + 18, and girls older than 9 years without +18, while girls aged 1 through 9 years with 18 had the best EFS. In terms of mortality, those younger than age 10 years with both +4 and +18 had an improved survival (96% vs 84% at 5 years, P < .0001). These findings confirm that the outcome of children with HeH is heterogeneous and that specific trisomies can identify patients with the greatest and least risk of treatment failure. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:2756 / 2762
页数:7
相关论文
共 50 条
  • [1] HIGH-HYPERDIPLOID CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA, SINGLE CENTRE EXPERIENCE
    Kourti, M.
    Athanassiadou, A.
    Sidi, V.
    Maria, L.
    Papakonstantinou, E.
    Stamatopoulos, K.
    Koliouskas, D.
    HAEMATOLOGICA, 2014, 99 : 548 - 548
  • [2] CLONAL ORIGINS OF HIGH-HYPERDIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA
    Alpar, D.
    Wren, D.
    Mansur, M. B.
    Potter, N. E.
    Bateman, C. M.
    Szczepanski, T.
    de Castro, D. Gonzalez
    Ford, A. M.
    Greaves, M.
    HAEMATOLOGICA, 2015, 100 : 199 - 199
  • [3] Comparative expressed sequence hybridization studies of high-hyperdiploid childhood acute lymphoblastic leukemia
    Gruszka-Westwood, AM
    Horsley, SW
    Martinez-Ramirez, A
    Harrison, CJ
    Kempski, H
    Moorman, AV
    Ross, FM
    Griffiths, M
    Greaves, MF
    Kearney, L
    GENES CHROMOSOMES & CANCER, 2004, 41 (03): : 191 - 202
  • [4] High Hyperdiploid Childhood Acute Lymphoblastic Leukemia
    Paulsson, Kajsa
    Johansson, Bertil
    GENES CHROMOSOMES & CANCER, 2009, 48 (08): : 637 - 660
  • [5] Genomic Heterogeneity and Clonal Evolution in High Hyperdiploid Childhood Acute Lymphoblastic Leukemia
    Woodward, Eleanor L.
    Yang, Minjun
    Moura-Castro, Larissa H.
    Spierings, Diana C. J.
    van den Bos, Hilda
    Foijer, Floris
    Paulsson, Kajsa
    BLOOD, 2021, 138
  • [6] Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia
    Ramos-Muntada, Mireia
    Trincado, Juan L.
    Blanco, Joan
    Bueno, Clara
    Rodriguez-Cortez, Virginia C.
    Bataller, Alex
    Lopez-Millan, Belen
    Schwab, Claire
    Ortega, Margarita
    Velasco, Pablo
    Blanco, Maria L.
    Nomdedeu, Josep
    Ramirez-Orellana, Manuel
    Minguela, Alfredo
    Fuster, Jose L.
    Cuatrecasas, Esther
    Camos, Mireia
    Ballerini, Paola
    Escherich, Gabriele
    Boer, Judith
    DenBoer, Monique
    Hernandez-Rivas, Jesus M.
    Calasanz, Maria J.
    Cazzaniga, Giovanni
    Harrison, Christine J.
    Menendez, Pablo
    Molina, Oscar
    MOLECULAR ONCOLOGY, 2022, 16 (16) : 2899 - 2919
  • [7] Specific expression of novel long non-coding RNAs in high-hyperdiploid childhood acute lymphoblastic leukemia
    Lajoie, Mathieu
    Drouin, Simon
    Caron, Maxime
    St-Onge, Pascal
    Ouimet, Manon
    Gioia, Romain
    Lafond, Marie-Helene
    Vidal, Ramon
    Richer, Chantal
    Oualkacha, Karim
    Droit, Arnaud
    Sinnett, Daniel
    PLOS ONE, 2017, 12 (03):
  • [8] Childhood Hyperdiploid Acute Lymphoblastic Leukemia
    Zaliova, Marketa
    Vaskova, Martina
    Hovorkova, Lenka
    Hrusak, Ondrej
    Stary, Jan
    Zuna, Jan
    BLOOD, 2015, 126 (23)
  • [9] Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia
    Raimondi, SC
    Pui, CH
    Hancock, ML
    Behm, FG
    Filatov, L
    Rivera, GK
    LEUKEMIA, 1996, 10 (02) : 213 - 224
  • [10] High-Hyperdiploid Acute Lymphoblastic Leukemia in Children with LZTR1 Germline Variants
    Brozou, Triantafyllia
    Borkhardt, Arndt
    Fischer, Ute
    Brandes, Danielle
    Yasin, Layal
    Haas, Oskar A.
    Junk, Stefanie
    Stanulla, Martin
    Anwar, Ammarah
    Soura, Stavrieta
    Hauer, Julia
    Auer, Franziska
    Dugas, Martin
    Walter, Carolin
    Varghese, Julian
    Reiff, Tobias
    Zipper, Lisa
    Hoffmann, Anna Emilia
    Wagener, Rabea
    BLOOD, 2023, 142